A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Treatment Gaining Popularity Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts said the demand for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.
Within minutes of joining one group, a seller shared contact information, where the majority of transactions take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these communities, posts display black plastic packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to possibly significant health risks”.
